135 related articles for article (PubMed ID: 2248620)
1. Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.
Eto M; Sato T; Watanabe K; Iwashima Y; Makino I
Atherosclerosis; 1990 Sep; 84(1):49-53. PubMed ID: 2248620
[TBL] [Abstract][Full Text] [Related]
2. Familial hypercholesterolemia and apolipoprotein E4.
Eto M; Watanabe K; Chonan N; Ishii K
Atherosclerosis; 1988 Aug; 72(2-3):123-8. PubMed ID: 3214464
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles.
Bioletto S; Fontana P; Darioli R; James RW
Atherosclerosis; 1998 May; 138(1):207-15. PubMed ID: 9678786
[TBL] [Abstract][Full Text] [Related]
4. Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese.
Kitahara M; Shinomiya M; Shirai K; Saito Y; Yoshida S
Atherosclerosis; 1990 Jun; 82(3):197-204. PubMed ID: 2375785
[TBL] [Abstract][Full Text] [Related]
5. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
Friedlander Y; Leitersdorf E
Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.
Horita K; Eto M; Makino I
Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694
[TBL] [Abstract][Full Text] [Related]
7. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.
Kobayashi T; Homma Y
J Clin Pharmacol; 2001 Oct; 41(10):1055-8. PubMed ID: 11583472
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphism and plasma cholesterol response to probucol.
Nestruck AC; Bouthillier D; Sing CF; Davignon J
Metabolism; 1987 Aug; 36(8):743-7. PubMed ID: 3600286
[TBL] [Abstract][Full Text] [Related]
10. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
11. Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum.
Watanabe A; Yoshimura A; Wakasugi T; Tatami R; Ueda K; Ueda R; Haba T; Kametani T; Koizumi J; Ito S; Ohta M; Miyamoto S; Mabuchi H; Takeda R
Atherosclerosis; 1981; 38(3-4):283-90. PubMed ID: 7225167
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.
Gibson JC; Goldberg RB; Rubinstein A; Ginsberg HN; Brown WV; Baker S; Joffe BI; Seftel HC
Arteriosclerosis; 1987; 7(4):401-7. PubMed ID: 3606467
[TBL] [Abstract][Full Text] [Related]
13. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
O'Malley JP; Illingworth DR
Metabolism; 1990 Feb; 39(2):150-4. PubMed ID: 2299987
[TBL] [Abstract][Full Text] [Related]
14. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
Helve E; Tikkanen MJ
Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E phenotypes and plasma lipids in young and middle-aged subjects.
Eto M; Watanabe K; Iwashima Y; Morikawa A; Oshima E; Sekiguchi M; Ishii K
Tohoku J Exp Med; 1986 Jan; 148(1):25-34. PubMed ID: 3705062
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E phenotype associations with plasma lipoproteins and bone mass in postmenopausal women.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Climacteric; 1998 Sep; 1(3):188-95. PubMed ID: 11907943
[TBL] [Abstract][Full Text] [Related]
17. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels.
Horita K; Eto M; Saito M; Nakata H; Iwashima Y; Ito H; Takahashi M; Kondo A; Morikawa A; Makino I
Artery; 1993; 20(6):324-36. PubMed ID: 8010888
[TBL] [Abstract][Full Text] [Related]
18. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
[TBL] [Abstract][Full Text] [Related]
19. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
[TBL] [Abstract][Full Text] [Related]
20. APO E gene and gene-environment effects on plasma lipoprotein-lipid levels.
Hagberg JM; Wilund KR; Ferrell RE
Physiol Genomics; 2000 Dec; 4(2):101-108. PubMed ID: 11120871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
